FEBRUARY 23-26, 2022 | MIAMI BEACH CONVENTION CENTER
2021 Accreditation/CME Information
Program Materials Requirements
Front Cover
- Miami Cosmetic Surgery and Aesthetic Dermatology
- August 25 - 28, 2021
- Miami Beach Convention Center
- This activity is jointly provided by Global Education Group and Informa Markets.
- This activity is supported by an educational grant from Allergan Aesthetics, an AbbVie Company; Merz Aesthetics; Galderma Laboratories; and Suneva Medical.
- This activity is supported by educational, in-kind grants of fillers, provided by Allergan Aesthetics, an AbbVie Company; Galderma Laboratories; Merz Aesthetics; Prollenium; Revance Aesthetics and Suneva Medical.
- This activity is supported by educational, in-kind grants of neurotoxins, provided by Allergan Aesthetics, an AbbVie Company; Galderma Laboratories; and Merz Aesthetics.
- This activity is supported by educational, in-kind grants of PDO suspension sutures provided by BENEV.
Target Audience
This activity has been designed to meet the educational needs of those Board Certified or Board Eligible in Plastic Surgery, Facial Plastic Surgery, Dermatology, and Oculoplastic Surgery, and Allied Health Professionals working directly with one of those specialists.
Statement of Need/Program Overview
The Miami Cosmetic Surgery conferenceaddresses the science, practice and techniques of aesthetic surgery and medicine. With a faculty featuring the foremost researchers, educators and practitioners, this event will provide cutting-edge content to advance knowledge, enhance skills and techniques, and improve outcomes. Miami Cosmetic Surgery will feature dynamic lectures delivered by prominent core experts at the forefront of the industry. These include the fields of Plastic Surgery, Facial Plastic Surgery, Dermatology, Oculoplastic Surgery and more.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe current safety and efficacy data and guideline recommendations of facial injectable products
- Discuss the mechanism of action of neurotoxin and dermal filler injections with individual patients
- Identify proper injection techniques that have demonstrated safe and satisfactory patient outcomes to minimize complications
- Review how to avoid the most common problems in rhinoplasty
- Explain the various approaches to blepharoplasty and brow lifting to determine the best suited for the patient
- Describe the best practices for choosing which patients might be the best candidates for surgical rejuvenation and which might benefit from non-invasive approaches to facial rejuvenation
- Identify options for minimally invasive facial rejuvenation using fillers, injectables, lasers and other skin tightening devices, and minimally invasive lifting techniques
- Review controversial topics in facial aesthetic surgery in order to make informed decisions
- Discuss various approaches to facelifting and which procedure is appropriate for which patient
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Informa Markets. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 15 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected]
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the posttest and evaluation. A link to do so will be emailed to you at the end of the meeting. If you have any questions, please contact Liddy Knight at [email protected]
Fee Information & Refund/Cancellation Policy
| Registreation Category | Super Early Bird Rate by 4/9/21 | Early Bird Rate by 6/7/21 | Regular Rate by 8/25/21 |
| Physician / Advanced Provider (DNP, FNP-C, ARNP, PA, PA-C) / Clinical Staff (RN, LPN)* | $795 | $995 | $1,195 |
| Practice Staff* (staff working in a medical practice) | $595 | $795 | $995 |
| Resident (valid proof of residency is required) | $395 | $495 | $595 |
| Industry (companies that sell products or services to the aesthetic medicine industry) | $4,900 | $4,900 | $4,900 |
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
| Last Name | First Name | Disclosures |
| AGUILERA, DO | Shino Bay | Nothing to disclose |
| ALMUKHTAR, MD | Rawaa | Nothing to disclose |
| BARED, MD | Anthony | Nothing to disclose |
| BOEHM, MD | Kristin | Nothing to disclose |
| BURROUGHS, MD | John | Nothing to disclose |
| CARR, MD | Emily | Nothing to disclose |
| CAUGHLIN, MD | Benjamin | Nothing to disclose |
| CHILUKURI, MD |
Suneel |
Consulting Fee: Allergan, Galderma Contracted Research: Allergan, Galderma, Merz, Prollenium Honoraria: Allergan, Prollenium" |
| CHERNOFF, MD | Gregory | Nothing to disclose |
| COHEN, MD | Steve | Consulting Fee: Apyx, Alastin, Permanique, Paracrine, Musculoskeletal Transplantation Foundation Contracted Research: Apyx, Alastin, Musculoskeletal Transplantation Foundation, Galderma, Merz Stock Shareholder: Millenium Medical Technologies, The Mage Group Royalties: The Mage Group |
| CROZIER, MD | Gordon | Nothing to disclose |
| DESYATNIKOVA, MD | Stella | Nothing to disclose |
| DUNCAN, MD | Diane | Nothing to disclose |
| EARLE, MD | Stephen Alexander | Nothing to disclose |
| FABI, MD | Sabrina | Consulting Fee: Allergan, Galderma, Merz, Revance, Endo, ROC Skincare, Bausch, Health, Exploramed |
| FEARMONTI, MD | Regina | Nothing to disclose |
| FEW, MD | Julius | Consulting Fee: Merz, 3D Matrix, Allergan, Revance, Sciton |
| FLAHERTY, MD | Patrick | Nothing to disclose |
| GASPAR, MD | Adrian | Nothing to disclose |
| GHALILI, MD | Michael | Nothing to disclose |
| GREEN, MD | Jeremy | Consulting Fee (e.g., Advisory Board): Allergan, Croma, Crown, Endo, Galderma, NC8, Revance |
| HALIM, MD | Azza | Nothing to disclose |
| HO, MD | Thuy-Van | Nothing to disclose |
| JOSEPH, MD | John | Consulting Fee: Galderma, Merz, Endo |
| KEANEY, MD | Terrence | Consulting Fee (e.g., Advisory Board): Allergan, Merz, Evolus, Candela |
| KHATRI, MD | Khalil | Speakers' Bureau: BTL |
| KWITKO, MD | Geoffrey | Nothing to disclose |
| LEE, MD | Wendy | Consulting Fee: Allergan, Galderma, Evolus, Revance, Mallinckrodt, Bausch Health, Osmotica, Horizon |
| LEWIS, MD | Amy | Nothing to disclose |
| MACK, MD | William | Nothing to disclose |
| MANDY, MD | Stephen H. | Nothing to disclose |
| MARTIN, MD | John | Other (Describe): InMode - clinical instructor |
| MCGINNISS, DO | Vincent | Nothing to disclose |
| MILLER, MD | Randy | Nothing to disclose |
| PERITO, MD | Paul | Consulting Fee (e.g., Advisory Board): Coloplast, Boston Scientific |
| PHILLIPS, MD | Katharine | Honoraria: Merck Manual, New York Times, Oakstone Publishing, Academic institutions and professional societies |
| POZNER, MD | Jason | Consulting Fee; Cytrellis, Sciton, Sofwaves Contracted Research: Cytrellis, Sciton Honoraria: Sciton, Lutronic, InMode Speaker's Bureau: Sciton, Lutronic, Cytrellis, InMode Stock Shareholder: Sciton, Cytrellis, Realself |
| ROMINE, MD | Kristine | Nothing to disclose |
| ROSENGAUS, MD | Frank | Consulting Fee (e.g., Advisory Board): Galderma |
| SALTZ, MD | Renato | Consulting Fee: Allergan, Symplast, Alastin, Dominion Aesthetics |
| SHEPHERD, MD | Jessica | Nothing to disclose |
| SHOJI, MD | Marissa | Nothing to disclose |
| SIPERSTEIN, MD | Robyn | Consulting Fee: Allergan, Galderma, Sciton |
| STEPHENS, DO | Alexis | Nothing to disclose |
| SULYMAN, MD | Tara | Other (Describe): PDO Max - Provided monetary grant and donated products for my research on PDO threads |
| TAGER, MD | Mark | Consulting Fee: Aethern, Sovereign Laboratories, Enzymedica, The American Nutrition Association, Eclipse Medical, EcoNugenics, Microbiome Labs, Pellecome, BioCorRX |
| WOODWARD, MD | Julie | Nothing to disclose |
| WULKAN, MD | Adam | Nothing to disclose |
| YU, MD | Arthur | Nothing to disclose |
| ZIMBRES, MD | Silvia | Consulting Fee: Allergan, J&J Speaker's Bureau: Allergan |
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner or Manager |
Reported Financial Relationship |
Rhys Williams, MSN, FNP-C, RN |
Nothing to disclose |
Lindsay Borvansky |
Nothing to disclose |
Andrea Funk |
Nothing to disclose |
Liddy Knight |
Nothing to disclose |
Ashley Cann |
Nothing to disclose |
Kim Rodriguez |
Nothing to disclose |
Erin Velardo |
Nothing to disclose |
Tawni Bosiljevac |
Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Informa Markets do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
